Cebix Incorporated

Industry

  • Pharmaceuticals
  • Biotechnology
    • Large Molecule

Other Names/Subsidiaries

  • Cebix AB
See more in Biomedtracker

Latest on Cebix Incorporated

Scrip

VC Roundup: Cleave Raises $37m To Maintain Phase I Momentum, Plus $233.5m In Recent Financings

 
• By Mandy Jackson

Cleave Biosciences Inc. has raised a $37m Series B round to fund two ongoing Phase I clinical trials for its lead drug candidate CB-5083, initiate a third trial, and to continue its hunt for therape

Scrip

Looking For The New Lantus: Next-Gen Diabetes Hopefuls Defy Risks

 
• By Melanie Senior

Type 2 diabetes isn’t an obvious spot for any aspiring biotech entrepreneur to invest hard-raised dollars. The highly competitive marketplace is dominated by Sanofi , desperate as $7 billion Lantu

Scrip

Recent Financings of Private Companies, November 2012

 
• By Deanna Kamienski, Beth Allan, Andrea Mancini, Amanda Micklus, Maureen Riordan, and Theresa Surprenant

IN VITRO DIAGNOSTICS Aushon BioSystems Inc. Aushon BioSystems raises $8.3mm through its Series C venture round Microarray instruments developer Aushon BioSystems Inc. has raised $8.3mm through

Scrip

Start-Up Execs On The Move, November 2012

 
• By Regina Paleski

Start-Up Execs Caprotec bioanalytics GMBH Jonathan Turner, PhD To:Managing Dir. & CEO (October) From:SVP, XL Techgroup Tel:+49 30 63 92 39 90 Cebix Inc. Joel Martin, PhD To:Pres. & CEO (October)